BioSpace News Archive

Business

Can High Blood Sugar (hyperglycemia) Haunt People with Diabetes Even After it is Under Control?

In people with diabetes, periods of high blood sugar (hyperglycemia) can negatively impact their health years later, even if they get their blood sugar under control.

September 9, 2020
·
8 min read
·
Chelsea Weidman Burke
BioSpace Global Roundup, Sept. 10

Biopharma and life sciences companies from across the globe provide updates on their businesses and pipelines.

September 9, 2020
·
8 min read
·
Alex Keown
Business

An Overview of Citi’s 15th Annual BioPharma Conference 2020 Boston

Like almost all conferences this year, Citi’s 15th Annual BioPharma Conference 2020 is being held virtually.

September 9, 2020
·
4 min read
·
Mark Terry
Drug Development

Preclinical Data Supports Efficacy for Pfizer, BioNTech Phase II/III COVID-19 Vaccine

Preclinical data for Pfizer and BioNTech’s Phase II/III COVID-19 mRNA vaccine candidate generated BNT162b2 strong anti-viral effects against an infectious SARS-CoV-2 challenge.

September 9, 2020
·
3 min read
·
Alex Keown
Job Trends

AstraZeneca Pauses Phase III COVID-19 Vaccine Trial Due to Patient Illness

AstraZeneca paused its Phase III COVID-19 vaccine trial following a report of an “unexplained illness” in a patient involved in the study.

September 9, 2020
·
3 min read
·
Alex Keown
Drug Development

Amryt Eyes Approval for Epidermolysis Bullosa Drug Filsuvez Following Phase III Data

This morning, Dublin-based Amryt said the primary endpoint of the late-stage study was met. Look at what else the phase III trial of Filsuvez depicted.

September 9, 2020
·
2 min read
·
Alex Keown
BioCapital

OncoImmune Raises $56 Million to Advance Anti-Inflammatory and Oncology Pipeline

Rockville, Maryland-based OncoImmune closed on a Series B round worth $56 million.

September 9, 2020
·
2 min read
·
Mark Terry
Drug Development

Feline Antiviral Therapy Shows Promise Against SARS-CoV-2 in Human Cells

A study published in Nature Communications on August 27 shows that a feline antiviral drug was effective at inhibiting the replication of human coronaviruses in cell cultures infected by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

September 9, 2020
·
2 min read
·
Brandon May
Deals

Avivagen Inc. Announces Proposed Extension of Warrants

Avivagen Inc. announces that it will be requesting approval from the TSX Venture Exchange for the extension of the expiration date of warrants exercisable to purchase 2,774,992 common shares at $0.90 per share, which were originally issued on June 1, 2016.

September 9, 2020
·
4 min read
Deals

GRAIL Announces Filing of Registration Statement for Proposed Initial Public Offering

GRAIL, Inc., a healthcare company whose mission is to detect cancer early, when it can be cured, announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of its common stock in the United States.

September 9, 2020
·
2 min read